Charlie Bolten
Gründer bei Solis Agrosciences, Inc.
Profil
Charlie W.
Bolten is the founder of Solis Agrosciences, Inc. (2021).
He is also the founder of Cadre Bioscience LLC.
Mr. Bolten's current jobs include Director positions at Immunophotonics, Inc., Euclises Pharmaceuticals, Inc., Aclaris Life Sciences, Inc., Prostate Management Diagnostics, Inc., BioGenerator (Venture Capital), Elira, Inc., Edison Agrosciences, Inc., Unleash Immuno Oncolytics, Inc., and Impetus Agriculture, LLC.
Mr. Bolten's former jobs include Director positions at Tansna Therapeutics, Inc., Arch Oncology, Inc., MediBeacon, Inc., Antegrin Therapeutics LLC, Nanopore Diagnostics LLC, Canopy Biosciences LLC, Principal Scientist & Project Leader at Pfizer Inc., Principal at Monsanto Co., and Associate Scientist at G.D.
Searle & Co., Inc. Mr. Bolten received an undergraduate degree from the University of Missouri.
Aktive Positionen von Charlie Bolten
| Unternehmen | Position | Beginn |
|---|---|---|
BioGenerator (Venture Capital)
 BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Präsident | 01.06.2009 |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Direktor/Vorstandsmitglied | - |
Euclises Pharmaceuticals, Inc.
 Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Direktor/Vorstandsmitglied | - |
Prostate Management Diagnostics, Inc.
 Prostate Management Diagnostics, Inc. BiotechnologyHealth Technology Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA. | Direktor/Vorstandsmitglied | - |
Immunophotonics, Inc.
 Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI. | Direktor/Vorstandsmitglied | - |
Elira, Inc.
 Elira, Inc. Medical/Nursing ServicesHealth Services Elira, Inc. develops a system to suppress appetite and assist diet adherence. The company was founded by John Faul in 2015 and is headquartered in St. Louis, MO. | Direktor/Vorstandsmitglied | - |
Unleash Immuno Oncolytics, Inc.
 Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | Direktor/Vorstandsmitglied | - |
Impetus Agriculture, LLC
 Impetus Agriculture, LLC Agricultural Commodities/MillingProcess Industries Impetus Agriculture, LLC is an American company that specializes in growing commercial biotech crops and developing bio pesticide formulations. The company was founded in 2018, and Martha Schlicher has been the CEO of the company since 2020. | Direktor/Vorstandsmitglied | - |
Edison Agrosciences, Inc.
 Edison Agrosciences, Inc. BiotechnologyHealth Technology Edison Agrosciences, Inc. provides agricultural biotechnology services. The firm specializes in agriculture, biotechnology and rubber. The company was founded by Matthew B. Crisp and Thomas M. Hohn and is headquartered in Creve Coeur, MO. | Direktor/Vorstandsmitglied | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Ehemalige bekannte Positionen von Charlie Bolten
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Charlie Bolten
| University of Missouri | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 19 |
|---|---|
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
Immunophotonics, Inc.
Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI. | Health Technology |
Euclises Pharmaceuticals, Inc.
Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Health Services |
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
Tansna Therapeutics, Inc.
 Tansna Therapeutics, Inc. Medical DistributorsDistribution Services Tansna Therapeutics, Inc. develops and offers oral drugs to treat epilepsy. It focuses on novel therapies for the treatment of central nervous system disorders. The company was founded by Max Baker in 2010 and is headquartered in St. Louis, MO. | Distribution Services |
Prostate Management Diagnostics, Inc.
Prostate Management Diagnostics, Inc. BiotechnologyHealth Technology Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA. | Health Technology |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
BioGenerator (Venture Capital)
BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Finance |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
Antegrin Therapeutics LLC
 Antegrin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Antegrin Therapeutics LLC develops novel therapies for fibrotic diseases. It focuses on idiopathic pulmonary fibrotic diseases, which are conditions that involve out-of-control scarring of organs. The company was founded by David Griggs and Peter Ruminski in 2012 and is headquartered in St. Louis, MO. | Health Technology |
Elira, Inc.
Elira, Inc. Medical/Nursing ServicesHealth Services Elira, Inc. develops a system to suppress appetite and assist diet adherence. The company was founded by John Faul in 2015 and is headquartered in St. Louis, MO. | Health Services |
Edison Agrosciences, Inc.
Edison Agrosciences, Inc. BiotechnologyHealth Technology Edison Agrosciences, Inc. provides agricultural biotechnology services. The firm specializes in agriculture, biotechnology and rubber. The company was founded by Matthew B. Crisp and Thomas M. Hohn and is headquartered in Creve Coeur, MO. | Health Technology |
Nanopore Diagnostics LLC
 Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Nanopore Diagnostics LLC develops a portable platform for counting microbes. The company is based in St. Louis, MO. The company was founded by Christoph Bausch and Tom Cohen. Tom Cohen has been the CEO since incorporation. | Health Technology |
Unleash Immuno Oncolytics, Inc.
Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | Health Technology |
Canopy Biosciences LLC
 Canopy Biosciences LLC Electronic Equipment/InstrumentsElectronic Technology Canopy Biosciences LLC engages in the provision of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. It offers crispr complete kits, mirna crispr knockout kits, clia certified services, compbio, mirna mimics, and cho complete. The company was founded by David Adam Smoller, Edward J. Weinstein and Crystal Winkeler in 2016 and is headquartered in St. Louis, MO. | Electronic Technology |
Cadre Bioscience LLC
 Cadre Bioscience LLC Pharmaceuticals: MajorHealth Technology Cadre Bioscience LLC develops novel therapeutics for human diseases. The company was founded by Charlie Bolten and is headquartered in Saint Louis, MO. | Health Technology |
Impetus Agriculture, LLC
Impetus Agriculture, LLC Agricultural Commodities/MillingProcess Industries Impetus Agriculture, LLC is an American company that specializes in growing commercial biotech crops and developing bio pesticide formulations. The company was founded in 2018, and Martha Schlicher has been the CEO of the company since 2020. | Process Industries |
Solis Agrosciences, Inc.
 Solis Agrosciences, Inc. Information Technology ServicesTechnology Services Solis Agrosciences, Inc. is a plant sciences company located in the 39N Innovation District. The American company offers technology and research services to agricultural innovators with the goal of designing and delivering new biotech plant traits in multiple crops using their proprietary Plant Pipeline as a Service (PPaaS™) for gene-edited and transgenic plant generation and characterization. Solis has a team of experienced scientists, entrepreneurs, and agtech leaders to support research needs and accelerate agricultural innovation to solve food and climate challenges. The company was founded by Charlie W. Bolten and the CEO is Tom Cohen. | Technology Services |
MediBeacon, Inc.
 MediBeacon, Inc. Medical SpecialtiesHealth Technology MediBeacon, Inc. provides optical diagnostic products and services. It offers Optical Renal Function Monitor, a platform focused on kidney function monitoring in real-time at the point-of-care. The company was founded by Steven J. Hanley and Richard B. Dorshow in 2012 and is headquartered in St. Louis, MO. | Health Technology |
